Targeting CD5 chimeric antigen receptor-engineered natural killer cells against T-cell malignancies.

Autor: Zu, Yingling1 (AUTHOR), Ren, Quan2 (AUTHOR), Zhang, Jishuai3 (AUTHOR), Su, Hongchang3 (AUTHOR), Lu, Qiumei3 (AUTHOR), Song, Yongping4 (AUTHOR) songyp@zzu.edu.cn, Zhou, Jian1 (AUTHOR) zhoujiandoctor@163.com
Zdroj: Experimental Hematology & Oncology. 10/26/2024, Vol. 13 Issue 1, p1-16. 16p.
Databáze: Academic Search Ultimate
Nepřihlášeným uživatelům se plný text nezobrazuje